Get started
Author

Mats O. Magnusson

Observed names: M. Magnusson, M. O. Magnusson, MO Magnusson, Mats Magnusson, Mats O Magnusson
ORCID: 0000-0001-6010-9153
Observed ORCID: 0000-0001-6010-9153
OpenAlex ID: A5101810802
Pharmacodynamics of Carbamazepine-mediated Induction of CYP3A4, CYP1A2, and Pgp as Assessed by Probe Substrates Midazolam, Caffeine, and Digoxin
2007 · MO Magnusson, M-L Dahl, et al. · Clinical Pharmacology & Therapeutics · 90
Outcome after percutaneous transluminal angioplasty of arterial stenosis in renal transplant patients
2009 · G. Hagen, J. Wadström, et al. · Acta Radiologica · 39
How Much Dose Can Be Saved in Three-Phase CT Urography? A Combination of Normal-Dose Corticomedullary Phase With Low-Dose Unenhanced and Excretory Phases
2012 · Pär Dahlman, Aart J. van der Molen, et al. · American Journal of Roentgenology · 38
Population Pharmacokinetics of a Novel Once-Every 3 Months Intramuscular Formulation of Paliperidone Palmitate in Patients with Schizophrenia
2016 · Mats O. Magnusson, Mahesh N. Samtani, et al. · Clinical Pharmacokinetics · 34
Safety, Tolerability, and Pharmacokinetics of Ribavirin in Hepatitis C Virus-Infected Patients with Various Degrees of Renal Impairment
2013 · B. J. Brennan, K. Wang, et al. · Antimicrobial Agents and Chemotherapy · 26
PDF
Quantitative analysis of eight testosterone metabolites using column switching and liquid chromatography/tandem mass spectrometry
2004 · Mats O. Magnusson, Rikard Sandström · Rapid Communications in Mass Spectrometry · 26
Dosing and Switching Strategies for Paliperidone Palmitate 3-Month Formulation in Patients with Schizophrenia Based on Population Pharmacokinetic Modeling and Simulation, and Clinical Trial Data
2017 · Mats O. Magnusson, Mahesh N. Samtani, et al. · CNS Drugs · 24
Exposure-efficacy analyses of nintedanib in patients with chronic fibrosing interstitial lung disease
2021 · Ulrike Schmid, Benjamin Weber, et al. · Respiratory Medicine · 15
Contrast enhancement in bladder tumors examined with CT urography using traditional scan phases
2013 · Malin Helenius, Pär Dahlman, et al. · Acta Radiologica · 14
A Mechanism-Based Integrated Pharmacokinetic Enzyme Model Describing the Time Course and Magnitude of Phenobarbital-Mediated Enzyme Induction in the Rat
2006 · Mats O. Magnusson, Mats O. Karlsson, et al. · Pharmaceutical Research · 10
Development of a population pharmacokinetic model of prucalopride in children with functional constipation
2016 · Erno van Schaick, Marc A. Benninga, et al. · Pharmacology Research & Perspectives · 9
PDF
Optimal Experimental Design for Assessment of Enzyme Kinetics in a Drug Discovery Screening Environment
2011 · Erik Sjögren, Joakim Nyberg, et al. · Drug Metabolism and Disposition · 8
Population Pharmacokinetics of Tenecteplase in Patients With Acute Myocardial Infarction and Application to Patients With Acute Ischemic Stroke
2022 · Fei Tang, Jurgen Langenhorst, et al. · The Journal of Clinical Pharmacology · 7
Comparison of quality of urinary bladder filling in CT urography with different doses of furosemide in the work-up of patients with macroscopic hematuria
2020 · A. Ljungberg, M. Segelsjö, et al. · Radiography · 7
PDF
Population Pharmacokinetics and Exposure‐Response for Dapirolizumab Pegol From a Phase 2b Trial in Patients With Systemic Lupus Erythematosus
2022 · Chayan Acharya, Mats O. Magnusson, et al. · The Journal of Clinical Pharmacology · 6
Accuracy of iodine quantification using dual-energy computed tomography with focus on low concentrations
2021 · Anders Ahnfelt, Pär Dahlman, et al. · Acta Radiologica · 5
PharmTeX: a LaTeX-Based Open-Source Platform for Automated Reporting Workflow
2018 · Christian Hove Rasmussen, Mike K. Smith, et al. · The AAPS Journal · 5
Pharmacodynamics of enzyme induction and its consequences for substrate elimination.
2007 · Mats O. Magnusson · KTH Publication Database DiVA (KTH Royal Institute of Technology) · 2
Writing reports of modelling and simulation analysis: Our experience in the field of pharmacometrics
2023 · Viviana Moroso, Mats Magnusson, et al. · Medical Writing · 1
PDF
A mechanistic model describing the impact of carbamazepine on the pharmacokinetics of clomethiazole and its metabolite NLA-715
2007 · Mats O. Magnusson, Per‐Henrik Zingmark, et al. · 1
Pharmacodynamics of enzyme induction attributable to carbamazepine treatment using midazolam, caffeine and digoxin as probe substrates
2007 · Mats O. Magnusson, Marja­‐Liisa Dahl, et al.
Diagnosis and Treatment of Transplant Renal Artery Stenosis with Short-Term Follow-Up
2004 · Gaute Hagen, Jonas Wadström, et al.
Works count: 22
Citation count: 367
H-index: 10
I10-index: 10
Year
Topic
Type